cycloheximide has been researched along with omeprazole in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (15.38) | 18.7374 |
| 1990's | 7 (53.85) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Clardy, J; Derbyshire, ER; Mota, MM; Prudêncio, M | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Daujat, M; Domergue, J; Fourtanier, G; Lesca, P; Maurel, P; Peryt, B | 1 |
| Maki, Y; Nagaya, H; Satoh, H | 1 |
| Blakeman, DP; Davis, JP; Im, WB | 1 |
| Blum, AL; Fimmel, CJ | 1 |
| Kinoshita, M; Noto, T; Saito, N; Tamaki, H | 1 |
| Okabe, S; Takahashi, S | 1 |
| Okabe, S; Takahashi, S; Yamazaki, T | 1 |
| Chen, D; Dartsch, C; Håkanson, R; Persson, L | 2 |
| Chen, D; Dornonville de la Cour, C; Håkanson, R; Lindström, E; Persson, L; Yamada, H; Zhao, CM | 1 |
| Ichihashi, M; Karaman-Jurukovska, N; Matsui, MS; Muizzuddin, N; Niki, Y; Petris, MJ; Yarosh, DB | 1 |
13 other study(ies) available for cycloheximide and omeprazole
| Article | Year |
|---|---|
Liver-stage malaria parasites vulnerable to diverse chemical scaffolds.
Topics: Animals; Anopheles; Antimalarials; Drug Evaluation, Preclinical; Hep G2 Cells; Humans; Inhibitory Concentration 50; Insect Vectors; Life Cycle Stages; Liver; Malaria; Malaria, Falciparum; Male; Mice; Mice, Inbred C57BL; Plasmodium berghei; Plasmodium falciparum; Treatment Outcome | 2012 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Omeprazole, an inducer of human CYP1A1 and 1A2, is not a ligand for the Ah receptor.
Topics: Adult; Benzoflavones; beta-Naphthoflavone; Binding, Competitive; Blotting, Northern; Cell Fractionation; Cells, Cultured; Cycloheximide; Cytochrome P-450 CYP1A2; Cytochrome P-450 Enzyme System; Dactinomycin; Enzyme Induction; Humans; Liver; Male; Omeprazole; Oxidoreductases; Poly A; Polychlorinated Dibenzodioxins; Receptors, Aryl Hydrocarbon; Receptors, Drug; RNA; RNA, Messenger | 1992 |
Possible mechanism for the inhibition of acid formation by the proton pump inhibitor AG-1749 in isolated canine parietal cells.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphate; Animals; Bucladesine; Carbachol; Cycloheximide; Dogs; Female; Gastric Acid; Histamine Antagonists; Lansoprazole; Male; Omeprazole; Parietal Cells, Gastric; Puromycin; Ranitidine | 1990 |
Irreversible inactivation of rat gastric (H+-K+)-ATPase in vivo by omeprazole.
Topics: Adenosine Triphosphatases; Animals; Anti-Ulcer Agents; Benzimidazoles; Cycloheximide; Dose-Response Relationship, Drug; Gastric Mucosa; H(+)-K(+)-Exchanging ATPase; Male; Omeprazole; Rats; Rats, Inbred Strains; Time Factors | 1985 |
Pepsin secretion: neurohumoral regulation and drug effects.
Topics: Animals; Anti-Ulcer Agents; Atropine; Benzimidazoles; Bucladesine; Carbachol; Cimetidine; Cycloheximide; Gastric Acid; Gastrins; Histamine; In Vitro Techniques; Mice; Models, Biological; Omeprazole; Parasympatholytics; Pepsin A; Secretory Rate | 1984 |
Reversible inhibition of rat gastric H+/K+-ATPase by T-330, 2-[2-dimethylaminobenzyl)sulfinyl]-1-(3-methylpyridine-2-yl)imidazole.
Topics: Animals; Cycloheximide; Enzyme Inhibitors; Gastric Acid; Gastric Mucosa; Imidazoles; Male; Mercaptoethanol; Omeprazole; Proton Pump Inhibitors; Pyridines; Rats; Rats, Sprague-Dawley | 1996 |
The cytoprotective effect of leminoprazole on indomethacin-induced damage to rabbit gastric mucosal cells.
Topics: 16,16-Dimethylprostaglandin E2; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Benzimidazoles; Cells, Cultured; Cycloheximide; Dactinomycin; Dinoprostone; Gastric Mucosa; Indomethacin; Male; NG-Nitroarginine Methyl Ester; Omeprazole; Rabbits | 1996 |
Leminoprazole protects cultured gastric mucosal cells against damage caused by ethanol, indometacin and taurocholate.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Benzimidazoles; Cell Membrane Permeability; Cell Survival; Cells, Cultured; Cholagogues and Choleretics; Cycloheximide; Dactinomycin; Dinoprostone; Ethanol; Gastric Mucosa; Indomethacin; Male; Omeprazole; Oxytocics; Protein Synthesis Inhibitors; Rabbits; Solvents; Taurocholic Acid | 1997 |
Multiple forms of histidine decarboxylase may reflect posttranslational activation.
Topics: Animals; Blotting, Western; Cycloheximide; Enzyme Activation; Gastric Mucosa; Gastrins; Histidine Decarboxylase; Isoenzymes; Omeprazole; Protein Processing, Post-Translational; Rats; RNA, Messenger | 1998 |
Histidine decarboxylase in rat stomach ECL cells: relationship between enzyme activity and different molecular forms.
Topics: Animals; Blotting, Western; Cycloheximide; Enterochromaffin-like Cells; Enzyme Inhibitors; Gastric Mucosa; Gastrins; Half-Life; Histidine Decarboxylase; Isoenzymes; Male; Omeprazole; Rats; Rats, Sprague-Dawley; Recombinant Proteins; RNA, Messenger | 1999 |
Rat stomach ECL cells: mode of activation of histidine decarboxylase.
Topics: Animals; Cycloheximide; Dactinomycin; Enterochromaffin-like Cells; Enzyme Activation; Fasting; Food; Gastric Mucosa; Gastrins; Histidine Decarboxylase; Male; Omeprazole; Postprandial Period; Protein Biosynthesis; Rats; Rats, Sprague-Dawley; Reserpine; RNA, Messenger | 2003 |
Omeprazole, a gastric proton pump inhibitor, inhibits melanogenesis by blocking ATP7A trafficking.
Topics: Adenosine Triphosphatases; Animals; Cation Transport Proteins; Cell Line, Tumor; Cells, Cultured; Copper-Transporting ATPases; Cycloheximide; Disease Models, Animal; Humans; Melanins; Melanocytes; Melanoma; Mice; Monophenol Monooxygenase; Omeprazole; Pigmentation; Protein Synthesis Inhibitors; Proton Pump Inhibitors; Skin; Skin Neoplasms; Ultraviolet Rays | 2015 |